G6PD and non-autoimmune hemolytic anemia: Although the data to support efficacy against malaria are limited, this dose has been associated with a limited and clinically apparent haemolytic anaemia in moderately G6PD-deficient subjects [48], but these findings do not conclusively indicate that non-specific administration of PQ is safe.